Australia markets close in 4 hours 23 minutes

Infinity Pharmaceuticals, Inc. (INFI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7998+0.0487 (+6.48%)
At close: 04:00PM EDT
0.8400 +0.04 (+5.03%)
After hours: 07:26PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
2,043
1,858
1,719
3,049
22,146
Cost of revenue
1,231
1,120
1,037
7,308
69
Gross profit
812
738
682
-4,259
22,077
Operating expenses
Research development
32,436
31,647
26,761
27,116
19,758
Selling general and administrative
14,284
14,174
12,418
14,289
14,248
Total operating expenses
46,720
45,821
39,179
41,405
34,006
Operating income or loss
-45,908
-45,083
-38,497
-45,664
-11,929
Interest expense
180
180
2,445
2,563
93
Total other income/expenses net
19
1
450
1,116
769
Income before tax
-46,069
-45,262
-40,492
-47,111
-11,253
Income tax expense
-
-
0
-54
0
Income from continuing operations
-46,069
-45,262
-40,492
-47,057
-11,253
Net income
-46,069
-45,262
-40,492
-47,057
-11,253
Net income available to common shareholders
-46,069
-45,262
-40,492
-47,057
-11,253
Basic EPS
-
-0.53
-0.68
-0.83
-0.20
Diluted EPS
-
-0.53
-0.68
-0.83
-0.20
Basic average shares
-
85,597
59,858
56,984
55,411
Diluted average shares
-
85,597
59,858
56,984
55,411
EBITDA
-
-44,602
-37,564
-44,329
-10,969